Andrew E. Place, MD
Quick facts
Marketed products
- Erwinia asparaginase · Oncology
Erwinia asparaginase depletes the amino acid asparagine in the bloodstream, starving leukemic cells that cannot synthesize their own asparagine.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about Andrew E. Place, MD
What are Andrew E. Place, MD's marketed drugs?
Top marketed products include Erwinia asparaginase.
Related
- Erwinia asparaginase · Oncology
- Sector hub: All tracked pharma companies